Authors/Disclosures
|
|
No disclosure on file |
|
Tomomi Yonekawa, MD
(Kyushu University Neurological Department)
|
No disclosure on file |
|
Noriko Isobe, MD
(Department of Neurology, Kyushu University)
|
Dr. Isobe has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion Pharma. Dr. Isobe has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Chugai Pharma . Dr. Isobe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe. Dr. Isobe has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis Pharma. Dr. Isobe has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Isobe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda Pharmaceutical. Dr. Isobe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Daiichisankyo. Dr. Isobe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. The institution of Dr. Isobe has received research support from Chugai Pharmaceutical. The institution of Dr. Isobe has received research support from Kyowa Kirin. The institution of Dr. Isobe has received research support from CSL Behring. The institution of Dr. Isobe has received research support from Boehringer Ingelheim. The institution of Dr. Isobe has received research support from Otsuka Pharma. The institution of Dr. Isobe has received research support from Sumitomo Pharmaceutical . The institution of Dr. Isobe has received research support from Eisai. |
|
Katsuhisa Masaki, MD
(Kyushu university)
|
No disclosure on file |
|
|
No disclosure on file |
|
Howard L. Weiner, MD
(Brigham and Women'S Hospital)
|
Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc.. |
|
Takuya Matsushita
(Department of Neurology, Neurological Institu)
|
No disclosure on file |
|
Jun-ichi Kira, MD, PhD
(Kyushu University)
|
Dr. Kira has nothing to disclose. |
|
|
No disclosure on file |
|
Satoshi Yoshimura, PhD
(Kyushu University)
|
No disclosure on file |